DIRS.INFO The most relevant business & tech news

☆ The Fed rate cut will boost these kinds of stocks the most, according to UBS
▼ + stars: | 2024-09-18 | by ( Sarah Min | ) www.cnbc.com time to read: +2 min

The Federal Reserve's interest rate cut will give a boost to these stocks, according to UBS. UBS strategist Patrick Palfrey identified stocks that have historically outperformed when the Fed lowers interest rates, a move that he expects will especially benefit smaller, more volatile and less-efficient companies. He expects this is true across the large-cap and small-cap universes represented by the S & P 500 and Russell 2000. Here are five S & P 500 stocks UBS expects can benefit most. By comparison, the SPDR S & P Regional Banking ETF (KRE) is up more than 8% year to date.

Persons: Patrick Palfrey, Russell, Palfrey Organizations: UBS, Regional Banking, CNBC, Moderna, Resources, National Bank Financial, Perpetua Resources Locations: ROE, Cleveland , Ohio, Idaho

☆ Lightning Round: Buy more Pfizer, says Jim Cramer
▼ + stars: | 2024-09-17 | by ( Jim Cramer | ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailLightning Round: Buy more Pfizer, says Jim Cramer'Mad Money' host Jim Cramer weighs in on stock including: Pfizer, First Solar, Six Flags, Equity Residential, Vertiv, Moderna, and Powell Industries.

Persons: Jim Cramer Organizations: Pfizer, First, Equity, Moderna, Powell Industries Locations: Vertiv

☆ Cramer's Lightning Round: 'Buy more' Pfizer
▼ + stars: | 2024-09-17 | by ( Julie Coleman | ) www.cnbc.com time to read: +1 min

Stock Chart Icon Stock chart icon Pfizer's year-to-date stock performance. Stock Chart Icon Stock chart icon First Solar's year-to-date stock performance. Stock Chart Icon Stock chart icon Equity Residential's year-to-date stock performance. Stock Chart Icon Stock chart icon Moderna's year-to-date stock performance. Stock Chart Icon Stock chart icon Vertiv's year-to-date stock performance.

Persons: Powell Organizations: Pfizer, Equity, Powell Industries

☆ What to know about the available Covid-19, flu and RSV vaccines
▼ + stars: | 2024-09-16 | by ( Deidre Mcphillips | ) edition.cnn.com time to read: +8 min

But the Covid-19 vaccines provided 54% protection against symptomatic infection last season, CDC data shows, despite new variants that cropped up. The updated Covid-19 vaccines are available now, but ideal timing for getting the shot may differ based on individual circumstances. Unlike the flu and Covid-19 vaccines, the RSV vaccine is one-time dose. The CDC says it’s also acceptable to get Covid-19, flu and RSV shots at one time, for those who are eligible. Covid-19, flu and RSV vaccines are widely available at pharmacies across the US.

Persons: CNN —, There’s, Mandy Cohen, ”, ” Dr, Sandra Fryhofer, Fryhofer, Katelyn Jetelina, it’s, Dr, Sanjay Gupta Organizations: CNN, US Centers for Disease Control, CDC, Moderna, Pfizer, American Medical, —, CNN Health Locations: United States

Ron DeSantis’ administration is once again advising against the mRNA vaccines: this time in the most vulnerable residents. In updated guidance for health care providers released Thursday, the Florida Health Department and state Surgeon General Joseph Ladapo questioned the safety and effectiveness of the mRNA Covid vaccines from Pfizer and Moderna, including for older adults and people with underlying health problems. Dr. Paul Offit, a vaccine expert at Children’s Hospital of Philadelphia, said the Florida surgeon general's guidance is unnecessarily alarming people about the Covid vaccines. "The mRNA vaccines are remarkably safe," he added. The CDC currently recommends everyone ages 6 months and older get an updated Covid vaccine this fall from any of the three options.

Persons: Ron DeSantis ’, Joseph Ladapo, Nature Cardiovascular Research , Paul Offit, Offit, They’re, Isaac Bogoch, ”, Boguch, Ladapo Organizations: Florida Health Department, Pfizer, Moderna, Nature Cardiovascular Research, Children’s Hospital of Philadelphia, Food and Drug Administration, United States, University of Toronto, CDC, Emergency Locations: Florida, U.S

☆ Stocks making the biggest moves midday: Moderna, Uber, Boeing, Adobe and more
▼ + stars: | 2024-09-13 | by ( Brian Evans | ) www.cnbc.com time to read: +3 min

Oracle — The stock rose nearly 2% after the database software company raised its fiscal 2026 revenue outlook . Uber — Shares of the ride-sharing company advanced more than 5% following news that it plans to expand its partnership with Alphabet's Waymo . Adobe — Shares tumbled 9% after the software company issued weaker-than-expected guidance for the current quarter. Unity Software — Shares of the game engine company added nearly 7%. Discovery — Shares advanced about 9% after the media conglomerate entered an early renewal agreement with Charter Communications.

Persons: Kevin Clark, RH —, Gary Friedman, Alphabet's Waymo, Uber, Stifel, Biden, David Zaslav, —, Jesse Pound, Sean Conlon, Samantha Subin, Hakyung Kim Organizations: JPMorgan, Oracle, Aptiv, — Stock, Adobe, Boeing, Unity, Holdings, PDD Holdings, Redfin Corporation, Federal Reserve, U.S, Home, Warner Bros, —, Charter Communications, Discovery Locations: U.S, Austin , Texas, Atlanta, China

(This is CNBC Pro's live coverage of Friday's analyst calls and Wall Street chatter. A biotech stock and an energy company were among the names being talked about by analysts on Friday. — Sean Conlon 6:19 a.m.: Pivotal says buy TKO Group A competitive media landscape could mean gains for TKO Group , according to Pivotal Research Group. TKO Group shares are up nearly 41% year to date. TKO YTD mountain TKO in 2024 — Sean Conlon 5:49 a.m.: JPMorgan downgrades Moderna to underweight JPMorgan sees a rocky road ahead for Moderna .

Persons: Raymond James, Srini Pajjuri, — Sean Conlon, Jeffrey Wlodarczak, Jessica Fye, Fye, it's, Ameet, Thakkar, he's, Fred Imbert Organizations: CNBC, JPMorgan, Moderna, BMO Capital Markets, GE Vernova, ARM, Research, JPMorgan downgrades Moderna, Food and Drug Administration, BMO, GE, General, Gas Power, General Electric Locations: Thursday's

☆ Here are Friday's biggest analyst calls: Nvidia, Netflix, Tesla, Kroger, Arm, Oracle, Eli Lilly, PNC, GE Vernova & more
▼ + stars: | 2024-09-13 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Here are Friday's biggest calls on Wall Street: Raymond James initiates Arm as outperform Raymond James said the semis company is well positioned for AI. Citi downgrades Capri Holdings to neutral from buy Citi said the risk/reward is more balanced for the owner of brands like Michael Kors. UBS reiterates Oracle as buy UBS raised its price target on the stock to $200 per share from $175. The feedback on Oracle's top-line growth was overall positive..." UBS reiterates PNC as buy UBS said the bank is a high conviction idea. " Citi resumes Eli Lilly as buy Citi resumed coverage of the stock and says it's well positioned.

Persons: Raymond James, Jefferies, SLG, CFRA, it's, datopotamab, Michael Kors, haven't, Morgan Stanley, EQT, Citi, Eli Lilly, Lilly, Tesla, BEV, Wells Organizations: Arm Holdings, ARM, Citi, Green, Kroger, Macquarie, Rio Tinto, Deutsche Bank, AstraZeneca, Deutsche, Capri Holdings, Barclays, Garmin, GM, BMO, GE, UBS, Oracle, Oracle's, PNC, JPMorgan, Netflix, JPMorgan downgrades Moderna, Nvidia, NVIDIA Locations: GenAI, New York, Rio, RIO, Las Vegas

☆ Stocks making the biggest moves premarket: Boeing, Oracle, Moderna and more
▼ + stars: | 2024-09-13 | by ( Samantha Subin | ) www.cnbc.com time to read: +1 min

Boeing — The stock sank 4% after Boeing factory workers went on strike early Friday after rejecting a new labor contract. Oracle — Shares of the database software company rallied more than 6%. Oracle lifted its fiscal 2026 revenue forecast and shared strong guidance for the 2029 fiscal year. RH — Shares of the home furnishings retailer surged 21% after a stronger-than-expected second quarter. Adobe — Shares sank more than 8% after the company issued softer-than-expected guidance for the current quarter.

Persons: Max, Kevin Clark, — CNBC's Michelle Fox, Lisa Han, Sarah Min, Jesse Pound Organizations: Boeing, Oracle —, Oracle, Moderna —, JPMorgan, —, Adobe —, Adobe, Aptiv, U.S . Securities, Exchange Commission, AstraZeneca —, Deutsche Bank

☆ Walmart and Clorox are among the most overbought stocks on Wall Street. Here are some others
▼ + stars: | 2024-09-13 | by ( Hakyung Kim | In Hakyungkim | ) www.cnbc.com time to read: +8 min

Retail giant Walmart is among this week's most overbought stocks, with an 14-day RSI reading of 81.7. The average price target on the Oakland, California-based stock is nearly 10% below the stock's current price, suggesting a pullback may lie ahead. Analysts estimate Halliburton and APA might rally nearly 60% each, while Occidental's price target is 38% above its current level. The average price target on the Oakland, California-based stock is nearly 10% below the stock's current price, suggesting a pullback may lie ahead. Analysts estimate Halliburton and APA might rally nearly 60% each, while Occidental's price target is 38% above its current level.

Persons: Clorox, Johnson, Let's, Gabby Jones, Cooper Organizations: Nasdaq, Dow Jones, CNBC Pro, Retail, Walmart, Consumer, Johnson, Energy, Halliburton, APA, . Occidental Petroleum, Occidental Petroleum, Pharmaceutical, Moderna, JPMorgan, Bloomberg, Getty, UDR UDR, Inc, Oracle Corp, CNBC, HAL Halliburton, APA APA Corp, Occidental Petroleum Corp, Walgreens, Body Locations: Arkansas, Oakland , California, Secaucus , New Jersey

☆ Stocks making the biggest moves premarket: Moderna, Alaska Air, Oxford Industries and more
▼ + stars: | 2024-09-12 | by ( Sarah Min | ) www.cnbc.com time to read: +1 min

Check out the companies making headlines before the bell: Alaska Air Group — Shares gained 5% after Alaska Air Group raised its third-quarter outlook, citing strong summer demand. The airline guided for per-share earnings in the range of $2.15 and $2.25, greater than prior guidance of $1.40 to $1.60 earnings per share. Moderna — Shares shed more than 6% after the drugmaker announced plans to slash expenses by $1.1 billion by 2027. Oxford Industries — Shares dropped 10% after the clothing company behind Tommy Bahama posted second-quarter figures that missed expectations. Oxford Industries posted adjusted earnings of $2.77 per share, lower than the FactSet consensus estimate of $3 earnings per share.

Persons: Moderna, Tommy Bahama, Kroger —, —, Alex Harring, Hakyung Kim, Jesse Pound, Samantha Subin Organizations: Alaska Air Group —, Alaska Air Group, Oxford Industries, Interpublic, Companies, UBS, U.S, Bancorp, U.S . Bancorp, Kroger, Diageo, Bank of America Locations: U.S

☆ 3-Stock Lunch: Moderna, Delta Air Lines & Signet Jewelers
▼ + stars: | 2024-09-12 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via Email3-Stock Lunch: Moderna, Delta Air Lines & Signet JewelersEva Ados, ERShares chief investment strategist, joins 'Power Lunch' to discuss stock plays for three stocks.

Persons: Signet Jewelers Eva Ados Organizations: Delta Air Lines, Signet Jewelers

☆ Moderna shares plunge on plans to cut $1.1 billion in costs, launch 10 new products by 2027
▼ + stars: | 2024-09-12 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

Moderna on Thursday said it plans to cut around $1.1 billion in expenses by 2027 and win approvals for several new products as it charts a path forward after the rapid decline of its Covid business. The company aims to trim R&D spending to a range of $3.6 billion to $3.8 billion in 2027, down from an expected $4.8 billion at the end of this year, according to a release. Moderna also has five non-respiratory products across cancer, latent viruses and rare diseases that could be approved by 2027, according to the company's release. The company expects 2025 revenue to come in at $2.5 billion to $3.5 billion. From 2026 to 2028, Moderna expects a compounded annual growth rate of more than 25% as new products launch.

Persons: Moderna, Stephane Bancel, Leerink, Mani Foroohar, Foroohar, Michael Yee, Bancel Organizations: Moderna, CNBC, Jefferies Locations: New York, U.S

☆ Stocks making the biggest moves midday: Kroger, Petco, Moderna, Roku and more
▼ + stars: | 2024-09-12 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

That builds on Wednesday's post-earnings rally of nearly 33%, which marked the stock's best day on record. Moderna — The stock plummeted nearly 16% after the drugmaker said it will cut $1.1 billion in expenses by 2027. Interpublic Group of Companies — The advertising stock was trading 2% lower following a downgrade from UBS to sell from neutral. U.S. Bancorp — The bank stock slipped nearly 2% despite announcing a dividend hike and a $5 billion share buyback plan. Oracle – Shares of the software company rose nearly 2% after Bernstein named it a top investment idea .

Persons: Kroger –, Kroger, Moderna, Adam Berlin, Bernstein, Yun Li, Michelle Fox, Sean Conlon, Samantha Subin, Lisa Kailai Han, Sarah Min Organizations: Kroger, Moderna, Gilead Sciences, Alaska Air Group, Interpublic, Companies, UBS, Amazon, Pfizer, Bancorp, Diageo, Bank of America, Wolfe Research, Oracle – Locations: Gilead, Alaska, U.S

☆ Moderna CEO: Plans to file Covid and flu combo shot with FDA by the end of the year
▼ + stars: | 2024-09-12 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailModerna CEO: Plans to file Covid and flu combo shot with FDA by the end of the yearStephane Bancel, Moderna CEO, joins 'Squawk Box' to discuss Moderna's recent stock performance, what could explain the stock's underperformance, and much more.

Persons: Stephane Bancel Organizations: Email Moderna, FDA, Moderna

☆ More free Covid tests will be available in late September, Biden admin says
▼ + stars: | 2024-08-23 | by ( Marlene Lenthang | Marlene Lenthang Is A Breaking News Reporter For Nbc News Digital. | ) www.nbcnews.com time to read: +1 min

Free Covid-19 tests will be available once again come late September, the Biden administration announced Friday. Under the program, four free Covid tests will be available by mail. “So as all of you prepare for travel and gatherings with family and the 2024 holiday season, don’t forget to go to Covidtests.gov to order your free tests,” she said. It comes as Covid rates have risen across most of the country over the summer, fueled by highly contagious new variants. Just Thursday, the Food and Drug Administration approved new Covid vaccines from Pfizer and Moderna, updated to better match the circulating strains of the virus.

Persons: Biden, Dawn O’Connell, O'Connell, ” Organizations: Department of Health, Human Services, Administration, Strategic Preparedness, Covid, Centers for Disease Control, Food and Drug Administration, Pfizer, Moderna Locations: Covidtests.gov

☆ New Covid shots are coming available. Here’s what experts say about when to get yours
▼ + stars: | 2024-08-23 | by ( Brenda Goodman | ) edition.cnn.com time to read: +5 min

CNN —Newly updated vaccines against Covid-19 will be in pharmacies soon, just as the US is experiencing a surge of infections. Experts say it depends on your health, whether you’ve recently had Covid-19, which vaccine you plan to get and when it’s convenient for you. For that reason, he’s going to hold off on getting the updated shot. Ranney noted that the updated mRNA shots from Pfizer and Moderna will probably be available first, with Novavax’s vaccine coming in a few weeks. “The reality is that we’ve had waves of Covid every summer for the last few years, and so I think we have to kind of do a reset or rethink about how we’re doing Covid vaccine delivery,” Hotez said.

Persons: you’ve, “ It’s, ”, Carlos del Rio, “, You’ve, Del, Paul Offit, Megan Ranney, Ranney, Peter Chin, “ I’m, I’m, you’re, ” Chin, Hong, Dr, Sanjay Gupta, Peter Hotez, ” Hotez Organizations: CNN, Covid, Emory University, Vaccine Education, Children’s Hospital of Philadelphia, Food, Yale School of Public Health, Pfizer, Moderna, University of California, ”, CNN Health, Texas Children’s Hospital Locations: Del Rio, San Francisco, Texas

☆ The rise of OpenAI and Microsoft's $13 billion bet on the AI startup
▼ + stars: | 2024-08-10 | by ( Magdalena Petrova | ) www.cnbc.com time to read: +1 min

OpenAI, the company behind the ChatGPT chatbot, was founded in 2015 by a number of researchers, academics and entrepreneurs, including Sam Altman, Greg Brockman and Elon Musk. At the time, OpenAI said Musk left to avoid a conflict of interest with his other company, Tesla , which was becoming increasingly focused on AI. In the years since, OpenAI has grown into one of the prominent leaders in AI development. OpenAI now reportedly generates annual revenue of $3.4 billion, and has notable customers, including PwC, Moderna and Estée Lauder. Microsoft has invested about $13 billion into the AI startup.

Persons: Sam Altman, Greg Brockman, Elon Musk, Altman, Brockman, Musk, OpenAI, Estée Lauder Organizations: Tesla, Moderna, Microsoft, Big Tech Locations: OpenAI

☆ Here are Monday's biggest analyst calls: Nvidia, Netflix, Apple, Walmart, Disney, Boeing, Robinhood, Berkshire Hathaway and more
▼ + stars: | 2024-08-05 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Morgan Stanley reiterates Disney as overweight Morgan Stanley lowered its price target on the stock to $110 per share from $130 but said it is sticking with Disney shares. Morgan Stanley upgrades Prosperity Bancshares to overweight from equal weight Morgan Stanley said the regional bank has "best in class capital and growing liquidity." Morgan Stanley initiates MKS Instruments as overweight Morgan Stanley said the controlling and measuring device manufacturing company is well positioned. Morgan Stanley reiterates Apple as overweight Morgan Stanley said it is sticking with the stock following its quarterly 10-Q report. " Morgan Stanley reiterates Walmart as overweight Morgan Stanley said it is sticking with its overweight rating on the stock following Walmart+ membership hitting a record high according to its survey checks.

Persons: Mizuho, Morgan Stanley, Disney, Lockheed Martin, Berkshire Hathaway, HOOD, Apple, Jefferies, Mars, Bernstein Organizations: Bank of America, Nvidia, Disney, Gulfport Energy, RBC, Lockheed, UBS, Berkshire, Berkshire Hathaway, Citi, RBC downgrades Moderna, Moderna, Walmart, underperform Bank of America, Netflix, Reuters, Kellanova, Boeing Locations: China, Gulfport, Berkshire, Underperform

☆ These stocks have fallen too much, too fast and could be due for a rebound after broad market sell-off
▼ + stars: | 2024-08-02 | by ( Hakyung Kim | ) www.cnbc.com time to read: +3 min

This week's market sell-off has pushed several stocks into oversold territory — potentially setting these names for a rebound in the future. Troubled cybersecurity stock CrowdStrike is the most oversold stock on the list with an RSI of just 13.6. Some of this week's most overbought companies include defense giant Lockheed Martin , tobacco company Philip Morris International and FirstEnergy . Of the names on the list, Lockheed Martin has the highest 14-day RSI reading of 93.7. LMT YTD mountain Lockheed Martin in 2024

Persons: Goldman Sachs, LULU, Lockheed Martin, Philip Morris Organizations: Nasdaq, Dow Jones, CNBC, Moderna, U.S, Street, Lockheed, Philip Morris International, Bank of America Locations: LSEG, Thursday's

☆ Three-Stock Lunch: Boeing, Moderna and Micron
▼ + stars: | 2024-08-02 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThree-Stock Lunch: Boeing, Moderna and MicronScott Nations, president of Nations Indexes, joins CNBC's 'Power Lunch' to discuss three stocks: Boeing, Moderna, and Micron.

Organizations: Boeing, Moderna, Micron Scott Nations, Nations, Micron

☆ Stocks making the biggest moves midday: Shake Shack, C.H. Robinson, Mobileye Global and more
▼ + stars: | 2024-08-01 | by ( Sean Conlon | ) www.cnbc.com time to read: +5 min

However, it topped second-quarter revenue estimates and posted a narrower-than-expected loss for the quarter. Teladoc — The telehealth stock moved more than 4% lower after the company posted weaker-than-expected second-quarter revenue. Air Products and Chemicals — The industrial gases company's stock surged more than 10% after beating Wall Street's earnings expectations. MGM Resorts — The stock declined nearly 14% despite the casino operator surpassing second-quarter earnings expectations. Crocs — The stock shares fell about 2% even though the company surpassed second-quarter earnings and revenue expectations.

Persons: Shack, C.H, Robinson, Teladoc, LSEG, Royce —, Royce, Wall, Meta, Carvana, Crocs, Akash Palkhiwala, —, Samantha Subin, Yun Li, Michelle Fox Organizations: LSEG, Moderna, Royce, Air Products, Chemicals, Meta, MGM Resorts, MGM, Arm, Holdings, Qualcomm Locations: LSEG ., U.S

☆ Moderna stock tumbles 21% as earnings show people aren't getting as many COVID shots
▼ + stars: | 2024-08-01 | by ( Kelly Cloonan | ) www.businessinsider.com time to read: +2 min

Moderna lowered its annual sales forecast as sales of its COVID-19 vaccine dropped by 37%. The company's vaccine sales struggled especially in Europe, where Pfizer has a deal until 2026. AdvertisementPeople are getting fewer COVID-19 shots, and it's hitting former vaccine heavyweight Moderna, new earnings show. The company's second quarter revenue dropped to $241 million, compared to $344 million a year ago, as sales of its COVID-19 vaccine dropped 37% year-over-year. Moderna also lowered its sales forecast for the year to between $3 billion and $3.5 billion, down from its previous forecast of around $4 billion.

Persons: —, it's, Stephane Bancel Organizations: Moderna, Pfizer, Service Locations: Europe, Moderna, Covid

☆ Moderna CEO Stephane Bancel on Q2 results, slashing its full-year sales guidance
▼ + stars: | 2024-08-01 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailModerna CEO Stephane Bancel on Q2 results, slashing its full-year sales guidanceModerna CEO Stephane Bancel joins 'Squawk Box' to discuss the company's quarterly earnings results, why the company is slashing its full-year sales guidance, state of the company's Covid vaccines, and more.

Persons: Stephane Bancel Organizations: Email Moderna

☆ Moderna stock falls more than 10% as it slashes guidance on low EU sales, tough U.S. vaccine market
▼ + stars: | 2024-08-01 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +5 min

It's Moderna's second-ever commercially available product after its Covid vaccine, which has seen demand plunge as the world emerges from the pandemic and relies less on protective shots and treatments. He added that "we've been having quite intense discussions with governments across Europe" to get Covid vaccine supply from Moderna. He is referring to the European Union's massive renegotiated Covid vaccine supply contract with Pfizer and its German partner BioNTech . Its shares are up nearly 20% this year on increasing confidence around its pipeline and messenger RNA platform, which is the technology used in its Covid vaccine and RSV shot. Moderna is also developing a stand-alone flu shot, a personalized cancer vaccine with Merck and shots for latent viruses, among other products.

Persons: It's Moderna's, Stephane Bancel, we've, Bancel, BioNTech, Moderna, I'm Organizations: Moderna Inc, Moderna, Pfizer, GSK, LSEG, Wall, Research, Merck Locations: Cambridge , Massachusetts, Europe, U.S, Moderna, Ukraine

Search resuls for: "modernă"

25 mentions found